We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Walkway at the entrance of the Novartis Campus in Basel, Switzerland

Investors Event Calendar

View recent presentations and learn more about upcoming events.

January 08, 2024
J.P. Morgan Healthcare Conference
San Francisco, USA

Doctor prescribing medication in Rwanda

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

ESG Updates: November 2023 (PDF 1.0 MB) | August 2023 (PDF 0.3 MB) | May 2023 (PDF 1.9 MB) | February 2023 (PDF 0.9 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)  | Materiality Assessment

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.


Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy

Novartis Annual Reporting Suite

Read and download our integrated report, annual regulatory filings, and other disclosures.


Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland